Dacihep 30
Brand Name: Dacihep 30
Generic Name: Daclastavir Dihydrochloride
Active
Registration Number
DR-XY47857
Dosage Form
Film Coated Tablet
Issuance Date
March 31, 2022
Expiry Date
March 31, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength30 mg
Packaging28 tablets in HDPE Bottle
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiviral for treatment of Hepatits C Virus (HCV) Infection
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Daclastavir DihydrochlorideActive
Monograph: daclastavir dihydrochloride